|
GH | Guardant Health, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ -0.01 |
| Leverage | 104.93% |
| Market Cap | $ 10.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -414.7m |
| Margin | -42.84% |
Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.